Stay updated on Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial
Sign up to get notified when there's something new on the Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial page.

Latest updates to the Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial page
- Check3 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, reflecting a new version in the page history.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4. This represents a minor build/version update and does not alter any study details, eligibility criteria, or results on the page.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page’s footer shows an updated platform/release revision from v3.5.2 to v3.5.3, with no changes to the displayed clinical study information.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This update is administrative and does not affect study details or user interactions.SummaryDifference0.1%

- Check96 days agoChange DetectedRevision metadata updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial page.